References
- Aspenberg P, Thorngren K-G, Lohmander L S. Rabbit bone matrix induces bone formation in the athymic rat. Acta Orthop Scand 1988; 58(3)276–8
- Bassett C A L, Hurley L A, Stinchfield F E. The fate of long-term anorganic bone implants. Transplant Bull 1962; 29: 423–51
- Burchardt H, Glowczewskie F P, Enneking W F. Short-term immunosuppression with fresh segmental fibular allografts in dogs. J Bone Joint Surg (Am) 1981; 63(3)411–5
- Chalmers J. Transplantation immunity in bone homografting. J Bone Joint Surg (Br) 1959; 41(1)160–79
- Goldberg V M, Bos G D, Heiple K G, Zika J M, Powell A E. Improved acceptance of frozen bone allografts in genetically mismatched dogs by immunosuppression. J Bone Joint Surg (Am) 1984; 66(6)937–50
- Hallen L G. Heterologous transplantation with kiel bone. Acta Orthop Scand 1966; 37: 1–19
- Hirano H, Marshall R, Urist M R. Induced bone development in transplants of fresh human pseudomalignant heterotopic ossification tissue in athymic nude mice. Clin Orthop 1991; 263: 113–20
- Homminga G N, Bulstra S K, Kuijer R, Linden A J. Repair of sheep articular cartilage defects with a rabbit costal perichondria! graft. Acta Orthop Scand 1991; 62(5)415–8
- Kino T, Hatanaka H, Hasimoto M, Nisiyama M, Goto T, Okuhara M, Kohsaka M, Aoki H, Imanaka H. FK506, a novel immunosuppressant isolated from a Streptomyces I fermentation, isolation and physicochemical and biological characteristics. J Antibiot 1987; 40: 1249–55
- Lagodzinski Z, Gorski A, Stepien-Sopniewska B, Wasik M. Effect of FK 506 on B cell responses. Transplant Proc 1991; 23: 942–3
- Morikawa K, Oseko F, Morikawa S. The distinct effects of FK506 on the activation, proliferation, and differentiation of human B lymphocytes. Transplantation 1992; 54: 1025–30
- Ochiai T, Nagata M, Nakajima K, Isono Inamura N, Nakahara K. Effects of FK506 on xenotransplantation of the heart and skin in a mouse-rat combination. Transplant Proc 1987; 19(5)84–6
- Valdivia L A, Fung J J, Demetris A J, Starzl T E. Differential survival of hamster to rat liver and cardiac xenograft under FK 506 immunosuppression. Transplant Proc 1991; 23(6)3269–71
- Walliser P, Benzie C R, Kay J E. Inhibition of murine B lymphocyte proliferation by the novel immunosuppressive drug FK506. Immunology 1989; 68: 434–5
- Weiss A, Imboden J B. Cell surface molecules and early events involved in human T lymphocyte activation. Adv Immunol 1987; 41: 1–38
- Woo J, Ildstad S T, Hronakes M L, Thomson A W. Kinetics of early T cell repopulation in the mouse following syngeneic bone marrow transplantation. FK506 causes a maturational defect of CD4+CD8-T cell. Transplant Proc 1991; 23: 2923–4